18th Project Portfolio and Resource Management Excellence for Pharma and Biotech 2024 | Marcusevans Group. | 13 February 2024 | The Madison Hotel, One Convent Road, Morristown, NJ 07960, USA

Transforming project and portfolio lifecycle management via strategic development plans, enriched leadership, and analysis of tools and data for optimal patient outcomes and health equity. This conference delves into the effective utilization of prioritization and resource management processes as well as methods for their sustainable execution. Attendees will walk away with transformative solutions to their challenges including external pricing and market pressures such as the Inflation Reduction Act (IRA), PMO and personnel leadership and empowerment tactics, tools and technological strategies such as AI and data architecture and the development and execution of Target Product Profiles (TPPs) and Asset Development Plans (ADPs). Benchmark against your peers and achieve maximum project, patient, health and commercial outcomes!

Key Sessions:

• Maximize effective resource management with a better understanding of your project and portfolio resourcing needs
• Establish clear guidelines for project and portfolio management decision-making
• Maintain organizational commitment to the use of PMO tools and processes
• Examine the impact of the Inflation Reduction Act (IRA) on drug development strategy
• Discover how AI and data analytics can be incorporated into portfolio management
• Explore the best practices for developing and optimizing target product profiles (TPPs)

2024 Speakers

Alison Curran
Sr. Director Program Management, Charles River

Saman Mazahreh, PhD
Senior Director, Supply Chain Management, Hikma Pharmaceuticals

Igor Rudychev, PhD, MBA
VP, Enterprise Analytics, Horizon Therapeutics

Alaina Kupec
Executive Director, Portfolio Strategy & Analytics, Gilead Sciences, USA

Randall White
Head of Development Program Management, Genmab

Josh Kaminetz
Project Portfolio Management Office Lead, Takeda

Michael Ferrante
Executive Director, Business Analytics, Regulatory Affairs and Clinical Safety, Merck

Claire Mierzwinski
Senior Director Translational SMA, Novartis

Robert Shapiro
Global Director, Portfolio Management, Apotex Inc.

Anusha Sivaramakrishnan
Executive Director, Head - Enterprise Project Management and Governance, Arvinas

Vamshi Gangupomu
Director, Strategy & Business Operations, Head of PMO, BMS

Jared Fantasia
Global Deployment Director, Program Management Office, Johnson & Johnson

Clement Pimor, Pharmaceutical Portfolio Management Consultant

Stephen Beckman
Chief Executive Officer, Yaral Pharma

Yasmin Khan
Asset Development Leader, Thermo Fisher Scientific

Patricia Neil
Head of Business Analytics and Operations, Gates Medical Research Institute

Daniel Patrick
Executive Director, Portfolio Management, Regeneron Pharmaceuticals

Jennifer Williams
Director of Operations, IPM

Edoardo Madussi, MSc, MBA
Head of Business Development, Intelligencia AI

Daryl Lubin
PMP, Principal Consultant, CMK Select

Phil Wolf
SVP, Products and Sales, PDWare

Eni Bica
Director of Operations, IPM

Kirk Dackow
Vice President, Consulting Delivery and Operations, CMK Select

2024 Sponsors

• IPM
• CMK Select
• PDWare
• Intelligencia AI